The Droplet Microarray (DMA) is a high-throughput platform for drug screening.
The Droplet Microarray (DMA) is a high-throughput platform for drug screening.
Distinguishing tumors from normal brain cells is important in diagnosis and is particularly challenging in glioma (a type of tumor that occurs in the brain and spinal cord) surgery due to the lack of clear interfaces between healthy and affected cells. Prof. Marie...
Implementing universal healthcare in low- and middle-income countries requires a robust implementation framework.
Brain tumors are among the leading causes of cancer‐related deaths, exhibiting poor prognoses with little improvement in outcomes over the past several decades.
Mitochondrial mutations as cell lineage tracers.
Harnessing an individual’s immune cells to mediate antitumor and antiviral responses is a life‐saving option for some patients with otherwise intractable forms of cancer and infectious disease.
A team of Canadian researchers developed and clinically tested a navigation‐guided fiberoptic Raman probe that allows surgeons to interrogate brain tissue in situ at the tip of the biopsy needle prior to tissue removal.
Chinese researchers combined a glow‐like helium atmospheric pressure plasma jet with clinical antitumor drug‐Tegafur‐ to treat pancreatic tumor cells in vitro.
In response to stress, cells must quickly reprogram gene expression to adapt and survive. This is achieved in part by altering levels of mRNAs and their translation into proteins.
A team of researchers develop a graphene-based tumor cell nuclear targeting fluorescent nanoprobe (GTTN) with a cell membrane permeability targeting mechanism.